Picture of POINT Biopharma Global logo

PNT — POINT Biopharma Global News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: POINT Biopharma To Publish Abstract At ESMO Congress 2022

Aug 18 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA TO PUBLISH ABSTRACT AT ESMO CONGRESS 2022
CONTAINING EFFICACY & SAFETY DATA FROM LEAD-IN COHORT OF PHASE 3
SPLASH TRIAL

Source text for Eikon:  ID:nGNX6vyz0K 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on POINT Biopharma Global

See all news